These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 30855134)
1. Disulfide Modified IgG1: An Investigation of Biophysical Profile and Clinically Relevant Fc Interactions. Bahou C; Love EA; Leonard S; Spears RJ; Maruani A; Armour K; Baker JR; Chudasama V Bioconjug Chem; 2019 Apr; 30(4):1048-1054. PubMed ID: 30855134 [TBL] [Abstract][Full Text] [Related]
2. Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan. Falconer DJ; Subedi GP; Marcella AM; Barb AW ACS Chem Biol; 2018 Aug; 13(8):2179-2189. PubMed ID: 30016589 [TBL] [Abstract][Full Text] [Related]
3. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations. Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058 [TBL] [Abstract][Full Text] [Related]
4. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types. Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding. Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P MAbs; 2015; 7(4):743-51. PubMed ID: 25970007 [TBL] [Abstract][Full Text] [Related]
7. Influence of disulfide bond isoforms on drug conjugation sites in cysteine-linked IgG2 antibody-drug conjugates. Liu-Shin L; Fung A; Malhotra A; Ratnaswamy G MAbs; 2018; 10(4):583-595. PubMed ID: 29436897 [TBL] [Abstract][Full Text] [Related]
8. Characterization of IgG1 Fc Deamidation at Asparagine 325 and Its Impact on Antibody-dependent Cell-mediated Cytotoxicity and FcγRIIIa Binding. Lu X; Machiesky LA; De Mel N; Du Q; Xu W; Washabaugh M; Jiang XR; Wang J Sci Rep; 2020 Jan; 10(1):383. PubMed ID: 31941950 [TBL] [Abstract][Full Text] [Related]
9. Highly homogeneous antibody modification through optimisation of the synthesis and conjugation of functionalised dibromopyridazinediones. Bahou C; Richards DA; Maruani A; Love EA; Javaid F; Caddick S; Baker JR; Chudasama V Org Biomol Chem; 2018 Feb; 16(8):1359-1366. PubMed ID: 29405223 [TBL] [Abstract][Full Text] [Related]
10. The impact of thioredoxin reduction of allosteric disulfide bonds on the therapeutic potential of monoclonal antibodies. Gurjar SA; Wheeler JX; Wadhwa M; Thorpe R; Kimber I; Derrick JP; Dearman RJ; Metcalfe C J Biol Chem; 2019 Dec; 294(51):19616-19634. PubMed ID: 31727737 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment. Zeng F; Yang C; Gao X; Li X; Zhang Z; Gong R J Biol Chem; 2018 Dec; 293(49):19127-19135. PubMed ID: 30327432 [TBL] [Abstract][Full Text] [Related]
12. Effect of the ADCC-Modulating Mutations and the Selection of Human IgG Isotypes on Physicochemical Properties of Fc. Wu HH; Crames M; Wei Y; Liu D; Gueneva-Boucheva K; Son I; Frego L; Han F; Kroe-Barrett R; Nixon A; Marlow M J Pharm Sci; 2022 Sep; 111(9):2411-2421. PubMed ID: 35760121 [TBL] [Abstract][Full Text] [Related]
13. Thioether-bonded constructs of Fab'gamma and Fc gamma modules utilizing differential reduction of interchain disulfide bonds. Kan KS; Anderson VA; Leong WS; Smith AM; Worth AT; Stevenson GT J Immunol; 2001 Jan; 166(2):1320-6. PubMed ID: 11145716 [TBL] [Abstract][Full Text] [Related]
14. Cleavage of the interchain disulfide bonds in rituximab increases its affinity for FcγRIIIA. Suzuki M; Yamanoi A; Machino Y; Kobayashi E; Fukuchi K; Tsukimoto M; Kojima S; Kohroki J; Akimoto K; Masuho Y Biochem Biophys Res Commun; 2013 Jul; 436(3):519-24. PubMed ID: 23764395 [TBL] [Abstract][Full Text] [Related]
15. Effect of trastuzumab interchain disulfide bond cleavage on Fcγ receptor binding and antibody-dependent tumour cell phagocytosis. Suzuki M; Yamanoi A; Machino Y; Ootsubo M; Izawa K; Kohroki J; Masuho Y J Biochem; 2016 Jan; 159(1):67-76. PubMed ID: 26254483 [TBL] [Abstract][Full Text] [Related]
16. Relative stabilities of IgG1 and IgG4 Fab domains: influence of the light-heavy interchain disulfide bond architecture. Heads JT; Adams R; D'Hooghe LE; Page MJ; Humphreys DP; Popplewell AG; Lawson AD; Henry AJ Protein Sci; 2012 Sep; 21(9):1315-22. PubMed ID: 22761163 [TBL] [Abstract][Full Text] [Related]
17. Global conformational changes in IgG-Fc upon mutation of the FcRn-binding site are not associated with altered antibody-dependent effector functions. Burvenich IJG; Farrugia W; Liu Z; Makris D; King D; Gloria B; Perani A; Allan LC; Scott AM; Ramsland PA Biochem J; 2018 Jul; 475(13):2179-2190. PubMed ID: 29794155 [TBL] [Abstract][Full Text] [Related]
18. The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass. Datta-Mannan A; Choi H; Stokell D; Tang J; Murphy A; Wrobleski A; Feng Y AAPS J; 2018 Sep; 20(6):103. PubMed ID: 30255287 [TBL] [Abstract][Full Text] [Related]
19. Engineering of the upper hinge region of human IgG1 Fc enhances the binding affinity to FcγIIIa (CD16a) receptor isoform. Ashoor DN; Ben Khalaf N; Bourguiba-Hachemi S; Marzouq MH; Fathallah MD Protein Eng Des Sel; 2018 Jun; 31(6):205-212. PubMed ID: 30299461 [TBL] [Abstract][Full Text] [Related]
20. Characterization of Disulfide Bond Rebridged Fab-Drug Conjugates Prepared Using a Dual Maleimide Pyrrolobenzodiazepine Cytotoxic Payload. Ruddle BT; Fleming R; Wu H; Gao C; Dimasi N ChemMedChem; 2019 Jun; 14(12):1185-1195. PubMed ID: 30980702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]